Abstract Aim-To investigate the effect of oral nifedipine on ocular blood flow in patients with low tension glaucoma (LTG). Methods-In this prospective study we examined the effects of 3 weeks of treatment with oral nifedipine 30 mglday in 11 patients with LTG, by using colour Doppler ultrasound imaging to measure haemodynamic variables in the central retinal (CRA), short posterior ciliary (SPCA), and ophthalmic (OA) arteries. Intraocular pressure (IOP) and blood pressures were also evaluated. Results-Nifedipine failed to alter IOP nor did it change peak systolic velocity, end diastolic velocity, or the resistance index in any of the three ocular vessels studied (p >0.05). However systolic and diastolic systemic arterial blood pressure measurements varied significantly after nifedipine treatment compared with baseline (p<0.05). A computed tomography scan of the head, carotid ultrasonography, complete blood cell count, evaluation for syphilis titres, Westergren erythrocyte sedimentation rate, and antinuclear antibody titres were all within normal limits. The study was approved by the institutional review board, and informed consent was obtained from all patients. Patients stopped using antiglaucoma drugs 3 weeks before entering the study. Baseline IOP, systemic blood pressure, and colour Doppler ultrasound values were measured. After the initial visit, patients were treated with nifedipine 10 mg three times daily for 3 weeks. At the completion of the treatment period, the three measurements were repeated.
Vasospasm has been suggested to play a role in the pathogenesis of low tension glaucoma (LTG) A computed tomography scan of the head, carotid ultrasonography, complete blood cell count, evaluation for syphilis titres, Westergren erythrocyte sedimentation rate, and antinuclear antibody titres were all within normal limits. The study was approved by the institutional review board, and informed consent was obtained from all patients. Patients stopped using antiglaucoma drugs 3 weeks before entering the study. Baseline IOP, systemic blood pressure, and colour Doppler ultrasound values were measured. After the initial visit, patients were treated with nifedipine 10 mg three times daily for 3 weeks. At the completion of the treatment period, the three measurements were repeated.
IOP was determined by Goldmann applanation tonometry, and arterial blood pressure was measured by sphygmomanometry. Sonographic examination was performed using a colour Doppler (Acuson128XP10 Mountain View, CA, USA) with a 7.5 MHz linear transducer. Both eyes of each patient were examined according to the protocol described previously by Lieb et al. 9 Scanning was performed in the axial view, thereby obtaining an overall view and permitting the identification of the precise location and direction of flow in the vessels. Vascular flow was evaluated by both colour and spectral Doppler modes. The Doppler angle was kept below 60 degrees. Blood flow measurements were studied for the ophthalmic (OA), short posterior ciliary (SPCA), and central retinal (CRA) arteries. CRA measurements were performed at approximately 2 mm posterior to the globe.
Posterior ciliary vessels were located either temporally or nasally adjacent to the optic nerve shadow. The same site was studied for subsequent measurements in each subject. The peak systolic, end diastolic, and the resistance index (RI) were calculated for each ofthe vessels tested.
PSV refers to the highest blood flow velocity achieved during systole and is calculated from the frequency of the peak in the Doppler shift spectral waveform. EDV refers to the lowest velocity occurring during diastole and is calculated from the frequency of the trough in the waveform. RI is defined as the difference between the maximum and minimum velocities of one cardiac cycle divided by the maximum velocity ( RI = PSV -EDV/PSV) and is a measure of peripheral vascular resistance.
The paired two tailed t test was used to evaluate the statistical significance of change from baseline of each of the measured Effect oforal nifedipine on ocular bloodflow in patients with low tension glaucoma Colour Doppler measurements were performed in the OA, CRA, and SPCA. Nifedipine did not significantly alter PSV, EDV, and the RI in any of the three ocular vessels studied (p >0.05, Figs 1, 2, and 3) .
Discussion
Most studies agreed that calcium channel blockers have a beneficial effect on visual functions of patients with LTG. Gasser and Flammer5 and Kitazawa et al6 reported that visual fields with various scotomata of some vasospastic LTG patients improved after the administration of calcium channels blockers. In a retrospective review of the charts of patients with normal tension glaucoma Netland et al observed that those on calcium channel blockers (diltiazem, nifedipine, and verapamil) appeared to do better than those not on the drugs,7 while nimodipine improved contrast sensitivity in LTG patients.8
It is believed that calcium channel antagonists influence visual function in patients with LTG by improving blood supply to the optic nerve head. We evaluated the effect of oral nifedipine on ocular haemodynamics using colour Doppler ultrasound imaging. Our measurements of the OA, SPCA, and CRA showed no significant differences in PSV, EDV 
